The Comparative Medical Costs of Atherothrombotic Disease in European Countries

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.9, 2003-01, pp. : 651-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Non-Medical Costs Associated with Visual Impairment in Four European Countries: France, Italy, Germany and the UK

By Lafuma Antoine

PharmacoEconomics, Vol. 24, Iss. 2, 2006-01 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite

Platelet Turnover in Atherothrombotic Disease

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5328-5343

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Relevance of Hyperhomocysteinaemia in Atherothrombotic Disease

By Stehouwer C.D.A.

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 251-260

Adis International

Access to resources Recommend Favorite

Platelet Function Testing in Atherothrombotic Disease

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5379-5391

Bentham Science Publishers

Access to resources Recommend Favorite

Costs and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease

By Migliaccio-Walle Kristen

PharmacoEconomics, Vol. 23, Iss. 7, 2005-01 ,pp. : 733-742

Adis International

Access to resources Recommend Favorite